acetylcysteine has been researched along with Grippe in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, PK; Hui, DS; Lee, N | 1 |
| Cai, Z; Chen, H; Gao, X; Liu, N; Song, W; Wang, P; Wu, H | 1 |
| Li, CH; Liu, BJ; Tian, SF; Wang, CL; Wang, GH; Wei, D; Xu, MJ; Xu, T; Zhang, RH | 1 |
| Millea, PJ | 1 |
| Cinatl, J; Doerr, HW; Geiler, J; Langer, K; Leutz, A; Michaelis, M; Naczk, P | 1 |
| Cheng, F; Lai, KY; Ng, WY; Osburga Chan, PK; Wong, KF | 1 |
| Jurenka, J; Roxas, M | 1 |
| Carati, L; De Flora, S; Grassi, C | 1 |
| Rountree, R | 1 |
3 review(s) available for acetylcysteine and Grippe
| Article | Year |
|---|---|
Adjunctive therapies and immunomodulatory agents in the management of severe influenza.
Topics: Acetylcysteine; Animals; Antibodies, Viral; Antiviral Agents; Humans; Immunologic Factors; Immunomodulation; Influenza, Human; Peroxisome Proliferator-Activated Receptors; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome; Viral Load | 2013 |
N-acetylcysteine: multiple clinical applications.
Topics: Acetaminophen; Acetylcysteine; Antidotes; Expectorants; Female; Free Radical Scavengers; Hearing Loss; Humans; Influenza, Human; Neoplasms; Polycystic Ovary Syndrome; Respiratory Tract Diseases | 2009 |
Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations.
Topics: Acetylcysteine; Antiviral Agents; Common Cold; Dehydroepiandrosterone; Humans; Influenza Vaccines; Influenza, Human; Lactoferrin; Nonprescription Drugs; Phytotherapy; Zinc | 2007 |
1 trial(s) available for acetylcysteine and Grippe
| Article | Year |
|---|---|
Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment.
Topics: Acetylcysteine; Administration, Oral; Aged; Antiviral Agents; Drug Administration Schedule; Female; Humans; Immunity, Cellular; Incidence; Influenza A virus; Influenza, Human; Italy; Male; Seasons; Time Factors | 1997 |
5 other study(ies) available for acetylcysteine and Grippe
| Article | Year |
|---|---|
Proteomics study of N-acetylcysteine response in H1N1-infected cells by using mass spectrometry.
Topics: Acetylcysteine; Amino Acid Sequence; Apoptosis; Cell Line, Tumor; Electrophoresis, Gel, Two-Dimensional; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Molecular Sequence Data; Proteins; Proteome; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
N-acetyl-l-cystine (NAC) protects against H9N2 swine influenza virus-induced acute lung injury.
Topics: Acetylcysteine; Acute Lung Injury; Animals; Antioxidants; Cytokines; Disease Models, Animal; Humans; Inflammation Mediators; Influenza A Virus, H9N2 Subtype; Influenza, Human; Lipid A; Lung; Male; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Peroxidase; Swine; Toll-Like Receptor 4; Virus Replication | 2014 |
N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus.
Topics: Acetylcysteine; Animals; Antiviral Agents; Cell Line, Tumor; Cells, Cultured; Chlorocebus aethiops; Gene Expression Regulation, Viral; Humans; Inflammation Mediators; Influenza A Virus, H5N1 Subtype; Influenza, Human; Vero Cells; Virus Replication | 2010 |
High-dose N-acetylcysteine therapy for novel H1N1 influenza pneumonia.
Topics: Acetylcysteine; Antiviral Agents; Drug Therapy, Combination; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Middle Aged; Pneumonia, Viral | 2010 |
Patient power. Arming yourself to fight the flu.
Topics: Acetylcysteine; Glucans; Humans; Immune System; Influenza, Human; Phytotherapy; United States | 2000 |